Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medical Device-Makers Face Dynamic Commercial Compliance Risks

Executive Summary

Erinn Hutchinson, a Philadelphia-based health industries risk consultant with PricewaterhouseCoopers LLP, talked to Medtech Insight about how she advises medical device companies – big and small – trying to market devices in a dynamic legal compliance environment.

You may also be interested in...



US Slams Supplier’s Defense in Kickback Case

The latest government filing in a False Claims Act case involving Coloplast counters the defendants’ argument that the case should be dismissed because the alleged kickbacks fell within the "discount" safe harbor.

Manufacturer Settles Foreign Bribery Allegations Linked To Distributor 'Slush Fund'

Analogic Corp. and its subsidiary BK Medical APS are paying almost $15m to settle allegations that BK conspired with distributors to commit fraud overseas.

CMS Still Focusing On Open Payments Education Rather Than Compliance

The Centers for Medicare and Medicaid Services hasn’t yet cracked down on missing Open Payments submissions, although the agency has financial penalties at its disposal, speakers said during a recent Food and Drug Law Institute webinar. Meanwhile, companies continue to face challenges in maintaining compliance to both federal and state payment disclosure requirements.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT104072

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel